S36ɳÁú»á

EN
S36ɳÁú»á - ÒªÍæ¾ÍÍæÉ³Áú»á
ÃÀ¹úÌÇÄò²¡Ð­»á¿ÆÑ§Äê»á±¨µÀÌÇÄò²¡»¼Õß½ÓÊܸÉϸ°ûÖÎÁƺóÍ£ÓÃÒȵºËØ
2023/06/28

S36ɳÁú»á - ÒªÍæ¾ÍÍæÉ³Áú»á

ÍâµØÊ±¼ä6ÔÂ23ÈÕ£¬£¬£¬£¬£¬Vertex Pharmaceuticals£¨¸£Ì©ÖÆÒ©£¬£¬£¬£¬£¬VRTX.US£©ÔÚÃÀ¹úÌÇÄò²¡Ð­»á¿ÆÑ§Äê»á£¨ADA£©ÉÏÐû²¼ÁËÆäÌÇÄò²¡¸Éϸ°ûÁÆ·¨VX-880ÁÙ´²1/2ÆÚÊÔÑéµÄ×îÐÂÊý¾Ý£¬£¬£¬£¬£¬ÔÚ½ÓÊܸù«Ë¾¸Éϸ°ûÁÆ·¨Ò»Äê¶àºó£¬£¬£¬£¬£¬Á½Ãû1ÐÍÌÇÄò²¡»¼Õß²»ÔÙÐèҪעÉäÒȵºËØ£¬£¬£¬£¬£¬²¢ÇÒ¼²²¡µÄÉúÎï±ê¼ÇÎïÏÔ×ÅïÔÌ­¡£¡£ÕâÒ»Êý¾ÝÔöÇ¿ÁËÈËÃǶԸÉϸ°ûÁÆ·¨ÎªÌÇÄò²¡»¼Õß´øÀ´¹¦Ð§ÐÔÖÎÓúµÄÏ£Íû¡£¡£

6ÔÂ24ÈÕ½ÒÏþÓÚ¡¶ÁøÒ¶µ¶¡·µÄÒ»Ïî×îÐÂÑо¿Ö¸³ö£¬£¬£¬£¬£¬È«ÌìÏÂÏÖÔÚÓÐ5.29ÒÚÌÇÄò²¡»¼Õߣ¬£¬£¬£¬£¬Ô¤¼Æµ½2050Ä꣬£¬£¬£¬£¬ÕâÒ»Êý×Ö½«ÔöÌíÖÁ13ÒÚ¡£¡£ÌìÏÂÎÀÉú×éÖ¯2021ÄêÐû²¼µÄ¡¶ÌÇÄò²¡µØÍ¼¼¯£¨µÚÊ®°æ£©¡·ÏÔʾ£¬£¬£¬£¬£¬ÖйúÊdzÉÈËÌÇÄò²¡»¼ÕßÈËÊý×î¶àµÄ¹ú¼Ò£¬£¬£¬£¬£¬2021ÄêÖйúÌÇÄò²¡ÈËÊýԼΪ1.4ÒÚ£¬£¬£¬£¬£¬Ô¤¼Æ2045Ä꽫µÖ´ï1.74ÒÚ¡£¡£

ÌÇÄò²¡¿ÉÒÔ·ÖΪ1ÐÍÌÇÄò²¡£¡£¨T1D£©¡¢2ÐÍÌÇÄò²¡£¡£¨T2D£©¡¢ ÈÑÉïÆÚÌÇÄò²¡µÈÀàÐÍ¡£¡£ÆäÖУ¬£¬£¬£¬£¬T1DÊÇÒ»ÖÖ×ÔÉíÃâÒßÐÔ¼²²¡£¬£¬£¬£¬£¬ÓÉÓÚÃâÒßϵͳ¹ýʧµØ¹¥»÷Òȵº¦Âϸ°û£¬£¬£¬£¬£¬µ¼ÖÂÒȵºËØÉøÍ¸È±·¦£¬£¬£¬£¬£¬»úÌåÎÞ·¨Î¬³ÖÕý³£µÄѪÌÇˮƽ¡£¡£T1D»¼Õß±ØÐèºã¾Ã×¢ÉäÒȵºËز¢ÅäºÏѪÌÇ¼à¿Ø£¬£¬£¬£¬£¬µ«ÌìÌì×¢ÉäÒȵºËز»µ«»á¸ø»¼Õß´øÀ´¼«´óµÄÍ´¿à£¬£¬£¬£¬£¬»¹¿ÉÄܻᵼÖµÍѪÌÇ¡¢ñ²ðïºÍ»èØÊµÈ²¢·¢Ö¢£¬£¬£¬£¬£¬ÑÏÖØµÄ¿ÉÄÜ»¹»áµ¼ÖÂéæÃü¡£¡£

ÔÚÖÚ¶àºòÑ¡ÖÎÁÆÕ½ÂÔÖУ¬£¬£¬£¬£¬Ìæ»»±»×ÔÉíÃâÒ߯ÆËðµÄ¦Âϸ°û±»ÒÔΪÊÇ×î¿¿½ü¡°ÖÎÓú¡±T1DµÄÒªÁì¡£¡£ÒȵºÒÆÖ²Òѱ»ÓÃÓÚÀÖ³ÉÖÎÁƲ»Îȹ̵ĸßΣT1D»¼Õߣ¬£¬£¬£¬£¬µ«¸ÃÒªÁì±£´æ¹©ÌåÆ÷¹Ù¹©Ó¦ÓÐÏÞ£¬£¬£¬£¬£¬Ðèºã¾Ã·þÓÃÃâÒßÒÖÖÆ¼ÁµÈ¾ÖÏÞ¡£¡£

2019Ä꣬£¬£¬£¬£¬ÃÀ¹ú¡¶Ê±´ú¡·ÖÜ¿¯½«ÌÇÄò²¡¸Éϸ°ûÁÆ·¨ÄÉÈë¸Ä±äδÀ´Ê®ÄêÒ½ÁƵÄ12´óÁ¢Òì·¢Ã÷ÁбíÖС£¡£½üÄêÀ´£¬£¬£¬£¬£¬Ô½À´Ô½¶àµÄ¹«Ë¾ÏòÌÇÄò²¡¸Éϸ°ûÁÆ·¨½ø¾ü¡£¡£

VertexÊý¾ÝϲÈË

VX-880µÄ1/2ÆÚÁÙ´²ÊÔÑé°üÀ¨A¡¢B¡¢CÈý²¿·Ö£¬£¬£¬£¬£¬¹²ÍýÏëÄÉÈë17Ãû1ÐÍÌÇÄò²¡ÖØÖ¢»¼Õߣ¬£¬£¬£¬£¬Æù½ñÒÑÓÐ6Ãû»¼Õß½ÓÊÜÁËVX-880µÄÖÎÁÆ£¬£¬£¬£¬£¬ÔÚ²î±ðˮƽÉϻָ´ÁËÒȵºËØÉøÍ¸£¬£¬£¬£¬£¬ÑªÌÇ¿ØÖÆ»ñµÃ¸ÄÉÆ¡£¡£

ÔÚA²¿·ÖÊÔÑéÖУ¬£¬£¬£¬£¬1Ãû»¼Õß½ÓÊÜÁ˰ë¼ÁÁ¿µÄVX-880ÖÎÁÆ£¬£¬£¬£¬£¬Ëæ·Ã9¸öԺ󣬣¬£¬£¬£¬½ÓÊܵÚ2¸ö°ë¼ÁÁ¿µÄÖÎÁÆ£¬£¬£¬£¬£¬µ«¸Ã»¼ÕßËæÍËÈ´³öÁËÊÔÑ飨Vertex³ÆÓë²»Á¼·´Ó¦Î޹أ©¡£¡£ÁíÍâ2Ãû»¼ÕßÔÚ½ÓÊÜÖÎÁƺóËæ·ÃÁè¼Ý12¸öÔ£¬£¬£¬£¬£¬×îºóÒ»´ÎÊä×¢ºó90Ììµ½12¸öÔ£¬£¬£¬£¬£¬ÍÑÀëÁËÒȵºËØÒÀÀµ£¬£¬£¬£¬£¬Hb1Ac£¨ÌÇ»¯ÑªºìÂѰ×£¬£¬£¬£¬£¬HbA1cÁè¼Ý6.5%ͨ³£±»Õï¶ÏΪÌÇÄò²¡£¡£©ÏÔ×ÅϽµ£¬£¬£¬£¬£¬ÆäÖÐһλ»¼ÕßµÄHb1Ac´Ó8.6%ϽµÖÁµÚ21¸öÔµÄ5.3%£¬£¬£¬£¬£¬Áíһλ»¼ÕßµÄHb1Ac´Ó7.6%ϽµÖÁ6.0%¡£¡£

B²¿·ÖÊÔÑéµÄ3Ãû»¼ÕßÈ«¼ÁÁ¿½ÓÊÜÖÎÁƺ󣬣¬£¬£¬£¬Ëæ·Ã29-80Ì죬£¬£¬£¬£¬ÊµÏÖÁËÄÚÔ´ÒȵºËرí´ï£¬£¬£¬£¬£¬ïÔÌ­ÁËÍâÔ´ÒȵºËØÊ¹Ó㬣¬£¬£¬£¬ÆÏÌÑÌÇÄ¿µÄ¹æÄ£Ê±¼ä»ñµÃ¸ÄÉÆ¡£¡£ÓëÁ½ÃûVX-880Êä×¢ºóËæ·Ãʱ¼äÁè¼ÝÒ»ÄêµÄ»¼ÕßÏàËÆ¡£¡£

VertexÐÂÎŏ峯£¬£¬£¬£¬£¬VX-880ÔÚÆù½ñΪֹËùÓиøÒ©µÄ»¼ÕßÖÐÆÕ±éÄÍÊÜÐÔÓÅÒì¡£¡£´ó´ó¶¼²»Á¼ÊÂÎñΪÇá¶È»òÖжÈ£¬£¬£¬£¬£¬Ã»Óб¬·¢ÑÏÖØµÄ²»Á¼ÊÂÎñ¡£¡£×î³£¼ûµÄ²»Á¼ÊÂÎñÊÇÍÑË®¡¢¸¹Ðº¡¢µÍþѪ֢ºÍƤÕî¡£¡£Ò»ÃûÊÔÑé¼ÓÈëÕß·ºÆðÁËÑÏÖØµÄµÍѪÌÇÊÂÎñ¡£¡£

2021Ä꣬£¬£¬£¬£¬VertexÐû²¼ÁËÊ×Àý½ÓÊÜVX-880ÖÎÁƵϼÕßµÄЧ¹û£¬£¬£¬£¬£¬Êý¾Ý¿°³Æ¾ªÑÞ¡£¡£ÔÚ½ÓÊܵ¥¼ÁÖÎÁƺóµÚ90Ììʱ£¬£¬£¬£¬£¬¸Ã»¼ÕßÌìÌìÒȵºËØÊ¹ÓÃÁ¿ïÔÌ­91%¡£¡£È»¶ø2022Äê5Ô£¬£¬£¬£¬£¬ÃÀ¹úʳÎïÒ©Æ·¼àÊÓÖÎÀí¾Ö£¨FDA£©ÒÔΪVX-880ȱ·¦×ã¹»Êý¾ÝÒÔÖ§³ÖÆä¼ÌÐøÔöÌíÊÔÑé¼ÁÁ¿£¬£¬£¬£¬£¬Òò¶ø½ÐÍ£ÁËÕâÏîÁÙ´²Ñо¿£¬£¬£¬£¬£¬µ«VertexÏòFDAÌṩÁ˸ü´ó¶¼¾Ý£¬£¬£¬£¬£¬FDA¾­ÓÉÁ½¸öÔÂÊÓ²ìºó£¬£¬£¬£¬£¬ÓÖɨ³ýÁË¡°ÁÙ´²Æú¾è¡±¡£¡£

ƾ֤×îеÄÊý¾Ý£¬£¬£¬£¬£¬VX-880µÄÁÙ´²ÊÔÑéÕýÔÚÀ©Õ¹ÖÁC²¿·Ö£¬£¬£¬£¬£¬Äܹ»Í¬Ê±ÎªÐ»¼Õ߸øÒ©£¬£¬£¬£¬£¬¶ø·ÇÒ»´ÎÖ»ÔÚÒ»¸ö»¼ÕßÉíÉϾÙÐÐÊÔÑé¡£¡£

¡°ÕâЩÊý¾Ý´ú±íÁËT1DDZÔÚÖÎÁƵĻù´¡ÐÔÏ£Íû£¬£¬£¬£¬£¬Ê¹ÎÒÃÇÀëDZÔÚÖÎÓúÁÆ·¨¸ü½üÁËÒ»²½£¬£¬£¬£¬£¬¡±Vertex1ÐÍÌÇÄò²¡¼²²¡ÇøÓòÖ÷¹Ü·ÑÀûÎ÷ÑÇ¡¤ÅÁÁø¿¨£¨Felicia Pagliuca£©²©Ê¿Ëµ£¬£¬£¬£¬£¬¡°ÕâЩÊý¾ÝÔÚÎÒÃÇÕûÌåµÄÑо¿ÐÔT1DÍýÏëµÄÅä¾°ÏÂÌØÊâÓÐÒâÒ壬£¬£¬£¬£¬ÓÉÓÚÓëVX-880ÏàͬµÄϸ°ûÊÇÎÒÃÇ1/2ÆÚVX-264ϸ°û¼Ó×°±¸ÍýÏëÒÔ¼°´¦ÓÚÑо¿½×¶ÎµÍÃâÒßÒȵºÏ¸°ûÍýÏëµÄ»ùʯ¡£¡£¡±

ÈÔÐè¸ü´ó¶¼Ä¿¡¢¸ü³¤Ê±¼äµÄÑéÖ¤

VX-880´ÓÓÕµ¼¶àÐÑĿϸ°û£¨iPSC£©³ö·¢£¬£¬£¬£¬£¬ÔÚÌåÍ⽫iPSCÓÕµ¼³ÉΪÒȵº¦Âϸ°û£¬£¬£¬£¬£¬ÔÙͨÏ꾡°ûÒÆÖ²ÊÖÒÕ£¬£¬£¬£¬£¬½«¿ÉÒÔÕý³£ÉøÍ¸ÒȵºËصÄÒȵº¦Âϸ°ûÒÆÖ²µ½1ÐÍÌÇÄò²¡»¼ÕßÌåÄÚ£¬£¬£¬£¬£¬´Ó¶ø½â¾ö»¼ÕßµÄÒȵºËØÒÀÀµ¡£¡£VX-880ͨ¹ý¸ÎÞ²ÂöÊä×¢¸øÒ©£¬£¬£¬£¬£¬ÐèÒªÁ¬ÏµÃâÒßÒÖÖÆ¼ÁÅäºÏʹÓ㬣¬£¬£¬£¬ÒÔ×èÖ¹ÃâÒßÇãÔþ¡£¡£

¡°Êý¾Ý¿´ÆðÀ´ÒѾ­¾¡¿ÉÄܵغÃÁË¡£¡£¡±ÃÀ¹ú·ÇÓªÀûÐÔÉúÎïҽѧÑо¿»ú¹¹Ë¹¿ËÀïÆÕ˹Ñо¿Ëù£¨Scripps Research£©¸Éϸ°ûר¼ÒÕäÄÝ¡¤ÂåÁÖ£¨Jeanne Loring£©Í¨¹ýµç×ÓÓʼþÏòÐÐҵýÌåSTATÌåÏÖ¡£¡£µ«ÂåÁÖÌáÐѵÀ£¬£¬£¬£¬£¬ÕâЩÊý¾ÝÈÔȻֻÀ´×ÔÉÙÊý»¼Õߣ¬£¬£¬£¬£¬²»°üÀ¨ÆäÖÐÒ»Ãû»¼ÕßµÄÕûÄêЧ¹û£¬£¬£¬£¬£¬¸Ã»¼ÕßÍ˳öÁËÑо¿£¬£¬£¬£¬£¬µ«VertexûÓÐ˵Ã÷ÏêϸԵ¹ÊÔ­ÓÉ¡£¡£

ÃÀ¹úÂõ°¢ÃÜ´óѧÄÚÉøÍ¸Ñ§¼Ò½ÜÒÁ¡¤Ë¹¿­ÀÕ£¨Jay Skyler£©ÌåÏÖ£¬£¬£¬£¬£¬»¼ÕßµÄÍ˳ö˵Ã÷ÎúVX-880µÄ¾ÖÏÞÐÔ£ºËü²»»áÖÎÓúËùÓÐÈË£¬£¬£¬£¬£¬²¢ÇÒ»á´øÀ´Î£º¦¡£¡£»£»¼Õß±ØÐè·þÓÃÃâÒßÒÖÖÆ¼Á£¬£¬£¬£¬£¬ÒÔ±ÜÃâËûÃǵÄÉíÌ寯ËðÖ²ÈëµÄϸ°û£¬£¬£¬£¬£¬¡°²»ÊÇÿСÎÒ˽¼Ò¶¼»áÊÜÒæ£¬£¬£¬£¬£¬ÈôÊÇÄãûÓлñµÃ×ã¹»µÄÁÆÐ§£¬£¬£¬£¬£¬±ØÐèÆ½ºâÃâÒßÒÖÖÆµÄΣº¦Óë´ÓÖÎÁÆÖлñµÃµÄÀûÒæ¡£¡£¡±

¾ÝSTAT±¨µÀ£¬£¬£¬£¬£¬Ò»Ð©×¨¼ÒÏ£Íû´Ë´ÎÐû²¼µÄÊý¾Ý¿ÉÒÔ¼ÓËÙÊÔÑéËÙÂÊ£¬£¬£¬£¬£¬ÒÔÌṩ¸ü¶à¹ØÓÚÖÎÁƹæÄ£ºÍÒ»Á¬Ê±¼äµÄÊý¾Ý¡£¡£Ó¢¹ú²¼Àï˹ÍжûҽѧԺ£¨Bristol Medical School£©ÐÅÓýÌÊÚ°£µÂΡ¤¸Ç¶û£¨Edwin Gale£©¼á³ÖʹÓøü¶àµÄÊý¾ÝºÍ¸üеÄÒªÁì¡£¡£Ëû˵£¬£¬£¬£¬£¬Ð§¹û¡°ÁîÈËÐË·Ü¡±£¬£¬£¬£¬£¬µ«ÈÔȻֻÓÐÁ½Ãû»¼Õß±¬·¢ÁË¡°Ï·¾çÐÔµÄЧ¹û¡±¡£¡£

ËäÈ»VertexÔÚ´Ë´ÎÅû¶µÄÊý¾Ý±¨¸æ³ÆÎÞÑÏÖØ²»Á¼ÊÂÎñ£¬£¬£¬£¬£¬µ«ÌÇÄò²¡¸Éϸ°ûÁÆ·¨µÄÇå¾²ÐÔÈÔÐèÒ»Á¬¹Ø×¢¡£¡£2023Äê3Ô£¬£¬£¬£¬£¬¹ú¼ÊҽѧÆÚ¿¯¡¶¸Éϸ°ûÓë·¢Óý¡·£¨Stem Cells and Development£©¿¯µÇµÄһƪÎÄÕÂÏÔʾ£¬£¬£¬£¬£¬Ò»Ãû½ÓÊÜiPSCȪԴϸ°ûÖÎÁÆ2ÐÍÌÇÄò²¡µÄ»¼Õß·ºÆðÁËδ³ÉÊì»ûÌ¥Áö£¨ÈªÔ´ÓÚÉúֳϸ°ûµÄÖ×Áö£©¡£¡£

¡°¿´ÆðÀ´ºÃµÃÁîÈËÄÑÒÔÖÃÐŵÄÊÂÇéÍùÍù×îºó±»·¢Ã÷²»¹ýÔÆÔÆ¡£¡£¡± ¸Ç¶û˵£¬£¬£¬£¬£¬¡°ÎÒÒÔΪÕ⣨ÌÇÄò²¡¸Éϸ°ûÁÆ·¨£©½«ÊÇδÀ´µÄÆ«Ïò£¬£¬£¬£¬£¬µ«»¹ÐèÒªºÜ³¤µÄʱ¼äÈ·ÈÏÆäÁÆÐ§¡£¡£Òò´Ë£¬£¬£¬£¬£¬Òª³ÖÉóÉ÷ÀÖ¹ÛµÄ̬¶È¡£¡£¡±

ÌÇÄò²¡¸Éϸ°ûÁÆ·¨¡°ÉýΡ±

Vertex½¨ÉèÓÚ1989Ä꣬£¬£¬£¬£¬´òÔìÁË3¿îÄêÏúÊÛ¶îÁè¼Ý10ÒÚÃÀÔªµÄÒ©Îï¡£¡£2018Äê5Ô¹«Ë¾ÊÐÖµÊ״εִï450ÒÚÃÀÔª£¬£¬£¬£¬£¬õÒÉíÈ«ÇòÒ©ÆóÊÐֵǰ25Ãû¡£¡£½üÄêÀ´£¬£¬£¬£¬£¬VertexÕýÔÚ·Å×ݼÓÂëÌÇÄò²¡¸Éϸ°ûÁÆ·¨¡£¡£

VX-880×î³õÓÉSemma TherapeuticsÑз¢£¬£¬£¬£¬£¬2019Ä꣬£¬£¬£¬£¬VtertexÒÔ9.5ÒÚÃÀÔªÏÖ½ðÊÕ¹ºÁËSemma£¬£¬£¬£¬£¬»ñµÃÁËSemmaÆìϵÄÁÆ·¨¡£¡£¼ÌÊÕ¹ºSemmaºó£¬£¬£¬£¬£¬2022Ä꣬£¬£¬£¬£¬VertexÓÖÒÔ3.2ÒÚÃÀÔªµÄ¼ÛÇ®ÊÕ¹ºÁËViacyte£¬£¬£¬£¬£¬»ñµÃÁËViacyteµÄÈý¸öÒÈÏÙ¸Éϸ°ûÁÆ·¨¹ÜÏߣ¨Ö¸´¦ÔÚÑз¢Àú³ÌÖеIJúÆ·Ïߣ©£¬£¬£¬£¬£¬ÒÔ¼°Ïà¹Ø¸Éϸ°û×÷Óý·Ö½âÊÖÒÕ¡¢Ï¸°û·â×°ÊÖÒÕºÍÃâÒßÇóýºóµÄ¶àÐÑĿϸ°û¡£¡£

SemmaºÍViacyte±»ÒÔΪÊÇÏÖÔÚÌìÏÂÉÏ×îÁìÏȵÄÁ½¼ÒÒȵºÔÙÉúÆóÒµ£¬£¬£¬£¬£¬Vertex½«ÕâÁ½¼ÒÆóÒµÊÕÈëÄÒÖк󣬣¬£¬£¬£¬ÀÖ³ÉõÒÉíÌÇÄò²¡¸Éϸ°ûÁÆ·¨µÄÍ·°Ñ½»ÒΡ£¡£ÏÖÔÚVertexÕýÔÚÑо¿Ê¹ÓöàÖÖÒªÁìÀ´Ïû³ý¸Éϸ°ûÁÆ·¨¶ÔÒ»Á¬ÃâÒßÒÖÖÆµÄÐèÇ󡣡£2023Äê3ÔÂ27ÈÕ£¬£¬£¬£¬£¬VertexÓë»ùÒò±à¼­Ã÷Ðǹ«Ë¾CRISPR Therapeutics£¨CRSP.US£©¸æ¿¢ÏàÖú£¬£¬£¬£¬£¬Ï£Íûͨ¹ýµ÷½â»ùÒò×é³É£¬£¬£¬£¬£¬¿ª·¢Ô½·¢ÈÝÒ×±»ËÞÖ÷½ÓÊܵÄ1ÐÍÌÇÄò²¡¸Éϸ°ûÁÆ·¨¡£¡£

½üÄêÀ´£¬£¬£¬£¬£¬±»ÒÔΪÊÇÌÇÄò²¡ÁÆ·¨Èý¾ÞÍ·µÄŵºÍŵµÂ£¨NVO.US£©¡¢ÀñÀ´£¨LLY.US£©ÒÔ¼°Èüŵ·Æ£¨SNY.US£©£¬£¬£¬£¬£¬Ò²ÔÚ½«×¢ÖØÁ¦ÑÓÉìÖÁÌÇÄò²¡¸Éϸ°ûÁÆ·¨¡£¡£

2015Ä꣬£¬£¬£¬£¬Èüŵ·ÆÐû²¼ÁªºÏµÂ¹úÉúÎïÊÖÒÕ¹«Ë¾Evotec¿ª·¢»ùÓÚ¸Éϸ°ûµÄÌÇÄò²¡ÖÎÁÆÒ©Î£¬£¬£¬£¬½«Ê¹ÓÃÈËÀà¸Éϸ°ûÉú²ú¹¦Ð§ÐÔÈ˦Âϸ°û£¬£¬£¬£¬£¬½ø¶ø¿ª·¢¦Âϸ°ûÌæ»»ÁÆ·¨¡£¡£Èüŵ·Æ»¹½«Ê¹ÓÃÈ˦Âϸ°û¿ªÕ¹¸ßͨÁ¿Ò©Îïɸѡ£¬£¬£¬£¬£¬ÅжϿɼ¤»î¦Âϸ°ûµÄС·Ö×ÓÒ©Îï»òÉúÎïÖÆ¼Á£¬£¬£¬£¬£¬¿ª·¢¦Âϸ°ûµ÷ÀíÐÔÐÂÐÍÌÇÄò²¡Ò©Î£¬£¬£¬£¬ÕâÀàÒ©ÎïÓÐÍûïÔÌ­»òÏû³ý×¢ÉäÒȵºËصÄÐèÇ󡣡£

2018Ä꣬£¬£¬£¬£¬ÀñÀ´ÓëÃÀ¹úÉúÎïÊÖÒÕ¹«Ë¾Sigilon¸æ¿¢Ò»ÏîÌÇÄò²¡Ï¸°ûÁÆ·¨ÏàÖú¿ª·¢Ð­Ò飬£¬£¬£¬£¬Ê¹ÓøÄÁ¼°æµÄ¸Éϸ°ûÁÆ·¨À´¿ª·¢1ÐÍÌÇÄò²¡Ï¸°ûÁÆ·¨£¬£¬£¬£¬£¬ÕâÏîÏàÖúÉæ¼°ÒȵºÏ¸°û·â×°ÊÖÒÕ£¬£¬£¬£¬£¬Äܹ»½µµÍÒìÌå¸Éϸ°ûÃâÒßÇãÔþ·´Ó¦£¬£¬£¬£¬£¬Í¬Ê±Äܹ»×èÖ¹ÏËά»¯·´Ó¦¡£¡£Í¬Ä꣬£¬£¬£¬£¬ÔÚÀñÀ´Ö®ºó£¬£¬£¬£¬£¬ÅµºÍŵµÂÒ²ÔöÇ¿¶Ô¸Éϸ°ûÁÆ·¨µÄͶÈ룬£¬£¬£¬£¬ÓëÃÀ¹ú¼ÓÖÝ´óѧÒÔ¼°ÃÀ¹ú¿µÄζû´óѧ¸æ¿¢ÏàÖú£¬£¬£¬£¬£¬ÒÔ¿ìËÙ¿ª·¢Äܹ»ÖÎÁÆ1ÐÍÌÇÄò²¡µÄÐÂÐÍÁÆ·¨¡£¡£

¿ç¹úÒ©Æó°¢Ë¹Àû¿µ£¨AZN.US£©ÔÚ2017ÄêÈë¾Ö£¬£¬£¬£¬£¬Ð¯ÊÖ¹þ·ð¸Éϸ°ûÑо¿Ëù£¨HSCI£©£¬£¬£¬£¬£¬½«Ò»ÖÖ¸Éϸ°ûÖÆÔìÈËÀà¦Âϸ°ûµÄÍ»ÆÆÐÔÊÖÒÕÓÃÓÚÆä»¯ºÏÎïÎÄ¿âµÄɸѡ£¬£¬£¬£¬£¬Ñ°Õҿɻָ´¦Âϸ°û»îÁ¦µÄDZÔÚÐÂÒ©¡£¡£±ðµÄÉÐÓÐSeraxis¡¢Unicyte¡¢NextCell Pharma¡¢Orgenesis¡¢PharmaCyteµÈÖÚ¶àÁ¢ÒìÒ©ÆóÒ²ÔÚ̽Ë÷ÌÇÄò²¡¸Éϸ°ûÁÆ·¨¡£¡£

ÖйúµÄiPSCϸ°ûÒ©ÎïÑз¢ÆóҵҲո¶ͷ½Ç£¬£¬£¬£¬£¬²»¹ý´ó¶à´¦ÓÚÁÙ´²Ç°Ñз¢¡¢INDÉ걨»ò¸Õ×îÏȹ¤Òµ»¯µÄ½×¶Î¡£¡£


·µ»Ø
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿